Survodutide Titration Planner

Pre-loaded with the Phase 2 escalation pattern. Survodutide is investigational; every field stays editable.

Compound
Vial setup
mg
mL
Concentration —
Titration schedule
Weeks Dose Frequency Volume / dose Units Total mg
Total weeks —
Total injections —
Total mg needed —
Vials needed —
Drug level over time

Drug level is an estimate of how much drug is in your body across the schedule, in relative units, not an absolute blood concentration. Use it to see how levels build to a steady state, how long that takes, and how a dose change or a gap shifts them. Compare points on the curve to each other, not to a target number.

About this compound

Planning a survodutide titration

A long escalation by design

Survodutide pairs GLP-1 with glucagon receptor activity, and its Phase 2 program used an extended step-up specifically to manage tolerability. The schedule is longer than the approved incretins for that reason, not because the doses are larger.

Its most specific evidence is hepatic

The Phase 2 program included a dedicated MASH trial with biopsy endpoints, which is a harder endpoint than liver-fat imaging and the strongest distinguishing evidence it has.

Investigational

No approved product exists. Phase 3 is in progress, and the escalation used here may change.

Scope & safety

PepRecon is a research and education resource. This page is for informational and laboratory-research purposes only. It is not medical advice, is not a recommendation to use any compound, and is not a protocol to follow. Titration schedules shown here are the ones used in published trials or commonly described in community practice; they are a starting point for modeling, not a prescription. Several compounds discussed here are not FDA-approved and their regulatory status can change. Consult a licensed healthcare provider before making any decision. Calculations run entirely in your browser and are not transmitted or stored unless you generate a share link.

Related tools